Assyro AI

Orange Book product · Brand (NDA)

MACRILEN

MACIMORELIN ACETATE

Brand (NDA)NDA 205598DISCN AETERNA ZENTARIS

At a glance

Dec 20, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Dec 20, 2017

    8 yr 7 mo ago

  2. Today

  3. Patent 8192719 expires

    Listed method-of-use patent (U-2220) expiration.

    Oct 12, 2027

    in 1 yr 4 mo

  4. Patent 8192719*PED expires

    Listed listed patent expiration.

    Apr 12, 2028

    in 1 yr 10 mo

Pharmaceutical detail

Active ingredient

MACIMORELIN ACETATE

Strength

EQ 60MG BASE/POUCH

Dosage form

FOR SOLUTION

Route

ORAL

TE code

Not listed

Application

NDA 205598

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8192719Oct 12, 2027in 1 yr 4 mo
U-2220
8192719*PEDApr 12, 2028in 1 yr 10 mo
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.